Pasithea Therapeutics Correlations
KTTA Stock | USD 3.18 0.01 0.31% |
The current 90-days correlation between Pasithea Therapeutics and ZyVersa Therapeutics is 0.15 (i.e., Average diversification). The correlation of Pasithea Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Pasithea Therapeutics Correlation With Market
Significant diversification
The correlation between Pasithea Therapeutics Corp and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and DJI in the same portfolio, assuming nothing else is changed.
Pasithea |
Moving together with Pasithea Stock
0.64 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.62 | GOSS | Gossamer Bio | PairCorr |
0.64 | INZY | Inozyme Pharma | PairCorr |
Moving against Pasithea Stock
0.64 | AMLX | Amylyx Pharmaceuticals | PairCorr |
0.6 | PRAX | Praxis Precision Med | PairCorr |
0.56 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.47 | AKRO | Akero Therapeutics | PairCorr |
0.44 | QNRX | Quoin Pharmaceuticals | PairCorr |
0.4 | EWTX | Edgewise Therapeutics | PairCorr |
0.35 | RNXT | RenovoRx | PairCorr |
0.68 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
0.67 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
0.62 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
0.62 | WMT | Walmart Aggressive Push | PairCorr |
0.52 | DIS | Walt Disney Aggressive Push | PairCorr |
0.49 | RDNT | RadNet Inc | PairCorr |
0.48 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
0.46 | T | ATT Inc Aggressive Push | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Pasithea Stock performing well and Pasithea Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pasithea Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
KPRX | 2.77 | (0.29) | 0.00 | (0.26) | 0.00 | 5.95 | 16.59 | |||
ZVSA | 4.67 | (0.99) | 0.00 | 0.60 | 0.00 | 9.17 | 78.93 | |||
SONN | 4.76 | (0.77) | 0.00 | 2.19 | 0.00 | 12.31 | 37.58 | |||
ZURA | 3.78 | (0.36) | 0.00 | (0.09) | 0.00 | 7.95 | 30.69 | |||
PHIO | 4.53 | (0.30) | 0.00 | (0.18) | 0.00 | 11.78 | 36.22 | |||
RNAZ | 7.63 | 1.05 | 0.10 | (0.44) | 6.52 | 22.00 | 68.80 | |||
QNRX | 6.21 | 0.47 | 0.07 | 0.37 | 6.73 | 17.65 | 74.46 |
Pasithea Therapeutics Corporate Management
Yassine Bendiabdallah | COO Clinics | Profile | |
MD BA | Ex CoFounder | Profile | |
Tiago Marques | CEO Director | Profile | |
Daniel Schneiderman | Chief Officer | Profile | |
Graeme Currie | Chief Officer | Profile |